Uppsala, Sweden, February 6, 2013 / B3C newswire / – Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, has announced the launch of an updated version of its Isolera™ Spektra software with improvements to the time and solvent saving step gradient optimization feature. The updated software uses TLC data from 2 to 10 different TLC runs to estimate where the individual sample components will elute, the percentage of strong solvent required and which cartridge is best capable of purifying the amount of sample to be purified.
This patent-pending technology helps chemists to tailor the purification to separate and purify between one and six compounds in the sample or even target one specific compound of interest, which can reduce purification costs 60% or more over conventional, non-compound specific linear gradients. Furthermore, the simplicity of the software makes it easy for even the most inexperienced users to take advantage of sophisticated purification strategies.
“The launch of the Biotage® Isolera™ Spektra in 2012 was a revolution in flash purification, moving 1-dimensional flash into 2D and 3D with a purification system capable of targeting specific compounds in complex mixtures, and even detecting the presence of normally invisible impurities beneath peaks of interest. It has and will continue to positively change the way we think about flash purification” says Dr. Sunil Rana, Product Manager, Biotage®. “This latest update extends the step-gradient application range to include the new high capacity Biotage® SNAP Ultra and Biotage ZIP® Sphere cartridges.”
For further information visit www.biotage.com or call: in Europe +46 18 56 57 10, in North America toll free 1 800 446 4752, in Japan +81 422 28 1233, other areas please call +46 18 56 57 10.
About Biotage
Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world’s top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage has 272 employees with sales of 428.4 MSEK in 2011. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.
Contact:
James Churchill
Marketing Communications
Biotage GB Ltd
Distribution Way
Dyffryn Business Park
Ystrad Mynach
Hengoed, Wales CF82 7TS
United Kingdom
Tel: +44 (0)1443 811 849
Mobile: +44(0)7875484778
Email: james.churchill@biotage.com
